Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Actuant Executives Adopt 10b5-1 Plans - Quick Facts

Actuant Corp. (ATU: Quote) announced that certain of its executives have adopted prearranged trading plans in accordance with guidelines specified by Rule 10b5-1 under the Securities Exchange Act of 1934 and the Company's policies with respect to insider sales.

As per the 10b5-1 plans, the executives (Arzbaecher, Goldstein, Kobylinski, Lampereur) will be exercising stock options and immediately selling the shares of Actuant stock because the underlying options are approaching the end of their 10 year term. In addition, Arzbaecher and Boel plan to sell certain shares held outright. The transactions may take place from time-to-time on or after April 5, 2012, subject to certain 10b5-1 plan criteria, including certain minimum price levels and daily volume activity.

Click here to receive FREE breaking news email alerts for Actuant Corp. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Oracle Corp. said Thursday after the markets closed that its first quarter profit fell slightly from last year, hurt mainly by higher income tax expenses even as revenue increased 3%. The company's quarterly earnings per share, excluding items, also came in below analysts' expectations as did its quarterly revenue. After ending the previous session mostly higher following the Federal Reserve's monetary policy announcement, stocks saw further upside during trading on Thursday. The gains on the day lifted the Dow and the S&P 500 to new record closing highs. Incumbent Colorado Sen. Mark Udall, D-Col., trails his Republican challenger in the latest Quinnipiac University poll, with more than a third of likely voters describing their U.S. Senate vote as a vote against President Barack Obama.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.